logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Koji Izutsu

National Cancer Center Hospital
H指数:52
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of lisocabtagene maraleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: 31-month follow-up of the phase 2 TRANSCEND FL study

来那度胺联合利妥昔单抗治疗复发或难治性滤泡性淋巴瘤的疗效与安全性：TRANSCEND FL研究31个月随访结果

International Journal of Clinical Oncology
IF2.8
2026-10-140
OAAI
Shinichi Makita; Hideki Goto; Koji Izutsu; Yuichi Baba; Merav Bar; Maria Strocchia; Prachi Ghodke; Rina Nishii; Takanori Teshima
A multi-center, single-arm, phase 2 trial of dasatinib in T follicular helper cell lymphomas

多中心、单臂、II期临床试验：达沙替尼在T滤泡辅助细胞淋巴瘤中的应用

Nature Communications
IF15.7
2026-10-050
OAAI
Sakurako Suma; Mamiko Sakata-Yanagimoto; Yasuhito Suehara; Takahide Ara; Hideki Goto; Kensuke Usuki; Koji Izutsu; Motoko Yamaguchi; Noriko Fukuhara; Emiko Sakaida; Ken Ohmachi; Atsushi Uehara; Kosei Matsue; Satoshi Kimura; Hirokazu Nagai; Dai Maruyama; Mitsutaka Nishimoto; Kengo Takeuchi; Naoya Nakamura; Takashi Terauchi; Manabu Fujisawa; Yoshiaki Abe; Kenichi Makishima; Keiichiro Hattori; Tatsuhiro Sakamoto; Naoki Kurita; Hidekazu Nishikii; Futoshi Yoshino; Kenichi Yoshida; Yuko Hashimoto; Tomohiro Kaneta; Seishi Ogawa; Naoto Keino; Masahiko Gosho; Hiroyuki Hosokawa; Christian Steidl; Koichi Hashimoto; Shigeru Chiba
Comparative outcomes of lisocabtagene maraleucel versus an external control arm in third-line or later relapsed or refractory follicular lymphoma

利萨库特根马拉鲁塞尔与外部对照臂在第三线或更晚复发或难治性滤泡性淋巴瘤中的比较结果

LEUKEMIA & LYMPHOMA
IF2.2
2026-06-070
OAAI
Nastoupil, Loretta Jo; Martin Garcia-Sancho, Alejandro; Izutsu, Koji; Cartron, Guillaume; Zausner Skarbnik, Alan Pierre; Reguera Ortega, Juan Luis; Goto, Hideki; Borchmann, Peter; Farazi, Thalia; Bar, Merav; del Rosario Olivera, Maria; Kumar, Jinender; De Benedetti, Marc; Gu, Fangyi; Stein, Dara; Han, Jenny; Palomba, Maria Lia
Long-term survival with lisocabtagene maraleucel in second-line large B-cell lymphoma from TRANSFORM

TRANSFORM研究中lisocabtagene maraleucel在二线治疗大B细胞淋巴瘤中的长期生存情况

Blood Advances
IF7.1
2026-05-010
PRE
Kamdar, Manali; Solomon, Scott R.; Arnason, Jon; Johnston, Patrick B.; Glass, Bertram; Bachanova, Veronika; Ibrahimi, Sami; Mielke, Stephan; Mutsaers, Pim; Hernandez-Ilizaliturri, Francisco; Izutsu, Koji; Morschhauser, Franck; Lunning, Matthew; Ribrag, Vincent; Lin, Yi; Bhatnagar, Rashmi; Braun, Robert; Montheard, Sandrine; Abramson, Jeremy S.
Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenström macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trial

帕尔托 Brutinib 在复发或难治性华氏巨球蛋白血症患者中的安全性和活性：开放标签、多中心、I/II 期 BRUIN 试验的 5 年随访

The Lancet Haematology
IF0
2026-04-300
PRE
M Lia Palomba; Manish R Patel; Toby A Eyre; Wojciech Jurczak; David Lewis; Thomas Gastinne; Shuo Ma; Jonathon B Cohen; Krish Patel; Jennifer R Brown; Lydia Scarfò; Talha Munir; Ewa Lech-Maranda; Marc S Hoffmann; Chaitra S Ujjani; Bita Fakhri; Michael L Wang; Koji Izutsu; Hirokazu Nagai; Constantine S Tam
Impact of the diagnosis-to-treatment interval on the survival of patients with CD5-positive diffuse large B-cell lymphoma

CD5阳性弥漫大B细胞淋巴瘤患者诊断至治疗间隔对其生存的影响

Annals of Hematology
IF2.4
2026-04-250
OAAI
Yuma Nato; Kana Miyazaki; Dai Maruyama; Hiroyuki Takahashi; Kazutaka Sunami; Eiju Negoro; Satsuki Murakami; Takahiro Okada; Nobuyuki Takayama; Yuri Miyazawa; Ilseung Choi; Shuji Momose; Yuto Kaneda; Masahiro Yoshida; Naoto Tomita; Tohru Murayama; Momoko Nishikori; Junji Hiraga; Kohtaro Toyama; Naoki Takahashi; Taro Masunari; Jun Takizawa; Isao Tawara; Naoko Asano; Koichi Ohshima; Koji Izutsu; Koji Kato; Ritsuro Suzuki; Motoko Yamaguchi
Real-world outcomes of chimeric antigen receptor T-cell therapy with pembrolizumab as holding and/or bridging therapy in relapsed/refractory primary mediastinal large B-cell lymphoma

嵌合抗原受体T细胞疗法联合帕博利珠单抗作为维持和/或桥接疗法在复发/难治性原发纵隔大B细胞淋巴瘤中的真实世界疗效

International Journal of Clinical Oncology
IF2.8
2026-04-130
PRE
Risa Nishiyama; Shinichi Makita; Anna Hiratsuka; Akiko Miyagi Maeshima; Kimiteru Ito; Yu Aruga; Chiaki Ikeda; Hirotaka Matsui; Wataru Takeda; Mai Takeuchi; Tetsuro Ochi; Noriko Iwaki; Suguru Fukuhara; Wataru Munakata; Koji Izutsu
Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies

基因融合检测算法的比较揭示了血液恶性肿瘤中常被忽视的驱动融合。

npj Precision Oncology
IF8
2026-04-040
OAAI
Zen Tamura; Yuki Saito; Yasunori Kogure; Yuji Oshikawa-Kumade; Suguru Fukuhara; Sumito Shingaki; Hirokazu Kariyazono; Yoshiya Kikukawa; Yuta Ito; Kota Mizuno; Yuichi Shiraishi; Kotoe Katayama; Seiya Imoto; Koji Izutsu; Koichi Murakami; Junji Koya; Keisuke Kataoka
Clonal analysis of a case with fluid overload-associated large B-cell lymphoma evolving from primary large B-cell lymphoma of the central nervous system

一例液体超负荷相关的大B细胞淋巴瘤（由中枢神经系统原发性大B细胞淋巴瘤演变而来）的克隆分析

Annals of Hematology
IF2.4
2026-03-110
OAAI
Yuta Ito; Yasunori Kogure; Akiko Miyagi Maeshima; Rika Hosoba; Suguru Fukuhara; Wataru Munakata; Kenichi Chiba; Ai Okada; Yuichi Shiraishi; Yoshitaka Narita; Koji Izutsu; Keisuke Kataoka
Lisocabtagene maraleucel in patients with relapsed or refractory marginal zone lymphoma (TRANSCEND FL): primary analysis results from the global, multicohort, single-arm, phase 2 study

利萨库特根马拉鲁塞尔在复发或难治性边缘区淋巴瘤患者中的应用（TRANSCEND FL）：一项全球、多队列、单臂、II期研究的主要分析结果

The Lancet
IF97.3
2026-02-120
PRE
M Lia Palomba; Stephen J Schuster; Reem Karmali; Alan P Skarbnik; Jeremy S Abramson; Kirit Ardeshna; Peter Borchmann; Brian T Hill; Alejandro Martin García-Sancho; Gianpaolo Marcacci; Aaron P Rapoport; Guillaume Cartron; Isabelle Fleury; Koji Izutsu; Manali Kamdar; Stephan Mielke; Anna Maria Barbui; Juan Luis Reguera Ortega; Loretta J Nastoupil; Sairah Ahmed
Preliminary analysis of a multicenter study of Pola-R-CHP in untreated Japanese patients with DLBCL (POLASTAR)

POLASTAR研究：Pola-R-CHP在未经治疗的日本DLBCL患者中的多中心初步分析

INTERNATIONAL JOURNAL OF HEMATOLOGY
IF1.8
2025-12-010
OA
Satake, Atsushi; Nagate, Yasuhiro; Miyawaki, Kohta; Fujiwara, Yuki; Ota, Shuichi; Muta, Tsuyoshi; Rai, Shinya; Tsurumi, Hisashi; Suzuki, Ritsuro; Miyake, Takaaki; Goto, Hideki; Fukuhara, Noriko; Sakata-Yanagimoto, Mamiko; Izutsu, Koji; Nishikori, Momoko; Shibayama, Hirohiko; Kumode, Takahiro; Ennishi, Daisuke; Shimose, Takayuki; Inubashiri, Naoki; Matsumura, Itaru; Akashi, Koichi; Kato, Koji
Japanese Dermatological Association Guidelines: Outlines of Japanese Guidelines for the Management of Primary Cutaneous Lymphomas 2025

日本皮肤科学会指南：2025年日本原发性皮肤淋巴瘤管理指南概述

The Journal of Dermatology
IF0
2025-11-070
OAAI
Toshihisa Hamada; Makoto Sugaya; Takashi Sakaida; Yoji Hirai; Hikari Boki; Takatoshi Shimauchi; Teruyoshi Hisamoto; Eiji Kiyohara; Kazuyasu Fujii; Ko Sunagawa; Saeko Ozaki; Kayoko Ohnishi; Koji Izutsu; Souichi Shiratori; Ryo Amagai; Kentaro Yonekura; Masashi Iwata; Tomomitsu Miyagaki; Hiroshi Koga; Hiroshi Uchi; Yasuhiro Nakamura
Efficacy and safety of fixed-duration venetoclax plus obinutuzumab in untreated Japanese CLL and SLL: a phase 2 study

固定疗程维奈克拉联合奥比妥珠单抗在未经治疗的日本CLL和SLL患者中的疗效与安全性：一项2期研究

INTERNATIONAL JOURNAL OF HEMATOLOGY
IF1.8
2025-11-010
OAAI
Izutsu, Koji; Watanabe, Mitsumasa; Toubai, Tomomi; Tsukamoto, Taku; Maruyama, Dai; Kumode, Takahiro; Fukuhara, Noriko; Ogawa, Natsumi; Satomi, Natsuko; Nishimura, Yasuko; Honda, Hideyuki; Chyla, Brenda; Takizawa, Jun

研究方向

暂未获取到该数据
S
Shigeru Chiba
H 指数:77论文数:764被引数:2.9万
M
Mineo Kurokawa
H 指数:68论文数:840被引数:1.9万
S
Suguru Fukuhara
H 指数:19论文数:161被引数:1,009
N
Noriko Fukuhara
H 指数:27论文数:319被引数:4,105
W
Wataru Munakata
H 指数:23论文数:185被引数:3,462
Y
Yoshinobu Kanda
H 指数:0论文数:10被引数:42
S
Seishi Ogawa
H 指数:113论文数:1,493被引数:5.5万
S
Shinichi Makita
H 指数:20论文数:121被引数:1,454
H
Hideki Goto
H 指数:21论文数:242被引数:1,524
R
Ritsuro Suzuki
H 指数:77论文数:640被引数:2.2万